Khaitan & Co Advised Symbiotec Pharmalab Pvt. Ltd. On Filing Its Draft Red Herring Prospectus For Proposed IPO

Khaitan & Co advised Symbiotec Pharmalab Pvt. Ltd. on filing its Draft Red Herring Prospectus for proposed IPO

The leading law firm in India, Khaitan & Co advised Symbiotec Pharmalab Pvt. Ltd. on filing its draft red herring prospectus (DRHP) for its proposed initial public offering, comprising a fresh issue and an offer for sale aggregating up to INR 21,800 million.

The Khaitan & Co deal team included Gautham Srinivas (Partner), Sathvik Ponnappa (Partner), Pulkit Singh Rahangdale, Anubhav Jaiswal, Sarvesh Sharma, Dharini Shanker, Anushaka Sharma, Swadha Swaroop, and Naman Seth.

Click to know more about Khaitan & Co

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.